tiprankstipranks
Chordia Therapeutics Inc. (JP:190A)
:190A
Japanese Market
190A
Chordia Therapeutics Inc.
RESEARCH TOOLSreports
Want to see JP:190A full AI Analyst Report?

Chordia Therapeutics Inc. (190A) Stock News & Sentiment

2 Followers
Chordia Therapeutics Sets Agenda for Q2 FY 2026 Financial and Pipeline Update
Premium
Company Announcements
Chordia Therapeutics Sets Agenda for Q2 FY 2026 Financial and Pipeline Update
1M ago
190A
Chordia Therapeutics Narrows Interim Loss but Maintains Full-Year Red-Ink Forecast
Premium
Company Announcements
Chordia Therapeutics Narrows Interim Loss but Maintains Full-Year Red-Ink Forecast
1M ago
190A
Chordia Therapeutics Doses First Patient in Rogocekib Expansion Cohort
Premium
Company Announcements
Chordia Therapeutics Doses First Patient in Rogocekib Expansion Cohort
2M ago
190A
Chordia Advances Rogocekib Leukemia Trial With FDA-Aligned Expansion Cohorts
Premium
Company Announcements
Chordia Advances Rogocekib Leukemia Trial With FDA-Aligned Expansion Cohorts
3M ago
190A
Chordia Regains Full Rights to CTX-177 After Ending Ono License Deal
Premium
Company Announcements
Chordia Regains Full Rights to CTX-177 After Ending Ono License Deal
3M ago
190A
Chordia Therapeutics’ Major Shareholder Diluted Below 10% After Warrant Exercises
Premium
Company Announcements
Chordia Therapeutics’ Major Shareholder Diluted Below 10% After Warrant Exercises
3M ago
190A
Chordia Therapeutics Narrows Quarterly Loss but Forecasts Continued Full-Year Red Ink
Premium
Company Announcements
Chordia Therapeutics Narrows Quarterly Loss but Forecasts Continued Full-Year Red Ink
4M ago
190A
More JP:190A News >

190A News on the Web

Chordia Therapeutics Sets Agenda for Q2 FY 2026 Financial and Pipeline Update
TipRanks News
Neutral
Chordia Therapeutics Narrows Interim Loss but Maintains Full-Year Red-Ink Forecast
TipRanks News
Bearish
Chordia Advances Rogocekib Leukemia Trial With FDA-Aligned Expansion Cohorts
TipRanks News
Bullish
Chordia Therapeutics Narrows Quarterly Loss but Forecasts Continued Full-Year Red Ink
TipRanks News
Bearish
Chordia Therapeutics to Record Grant Income in Fiscal Year 2026
TipRanks News
Neutral
Chordia Therapeutics Restructures Capital to Strengthen Financial Foundation
TipRanks News
Neutral
Chordia Therapeutics Reports Fiscal Year 2025 Financial Results
TipRanks News
Neutral
Chordia Therapeutics Reports Continued Losses in Latest Financial Results
TipRanks News
Neutral

News Score - Last 7 Days

Negative
JP:190A
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week0%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:190A’s Media Buzz Sentiment?
2 articles about JP:190A were published this week. In an average week, 1 articles are published.
    What is JP:190A’s weekly average amount of articles?
    In an average week, 1 articles about JP:190A are published.
      What is JP:190A’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      TVTXTravere Therapeutics
      HVOOpen Orphan Plc
      PBMPsyence Biomedical
      QDELQuidelOrtho
      Showing the stocks with the most bullish news sentiment over the past week